Jul 31, 2026 04:30AM
Apr 13, 2026 07:00AM
Mar 9, 2026 02:30AM
Feb 3, 2026 02:30AM
Oct 1, 2025 07:00AM
Oct 1, 2025 07:00AM
Sep 24, 2025 02:30AM ENHERTU® Plus Pertuzumab Granted Priority Review in the U.S. as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer
Jan 13, 2025 02:00AM
Oct 1, 2024 02:00AM
Apr 2, 2024 02:00AM
Feb 19, 2024 02:00AM
Jan 29, 2024 07:00AM
Jan 29, 2024 02:00AM
Dec 22, 2023 08:00AM Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Apr 20, 2023 09:00PM
Oct 24, 2022 08:00AM
Jul 25, 2022 07:00AM
Jul 25, 2022 02:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 02:00AM

15,649 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All